Logo do repositório
 
Publicação

COVID-19 Vaccine Effectiveness among older adults

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorLaniece Delaunay, Charlotte
dc.contributor.authorMateo-Urdiales, Alberto
dc.contributor.authorPérez-Gimeno, Gloria
dc.contributor.authorO'Reilly, Karen
dc.contributor.authorUras, Marina
dc.contributor.authorErdwiens, Annika
dc.contributor.authorMlinaric, Ivan
dc.contributor.authorTúri, Gergo
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorMeijer, Adam
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorLazar, Mihaela
dc.contributor.authorLatorre-Margalef, Neus
dc.contributor.authorLucaccioni, Héloïse
dc.contributor.authorVerdasca, Nuno
dc.contributor.authorBella, Antonino
dc.contributor.authorRafael de la Cruz Lopez, Maria Angeles
dc.contributor.authorKelly, Eva
dc.contributor.authorEnouf, Vincent
dc.contributor.authorTolksdorf, Kristin
dc.contributor.authorPuzelli, Simona
dc.contributor.authorIbáñez Pérez, Ana Carmen
dc.contributor.authorFitzgerald, Margaret
dc.contributor.authorMasse, Shirley
dc.contributor.authorOh, Djin-Ye
dc.contributor.authorKaczmarek, Marlena
dc.contributor.authorBacci, Sabrina
dc.contributor.authorKissling, Esther
dc.contributor.authorVEBIS Primary Care Vaccine Effectiveness Group
dc.date.accessioned2026-10-07T09:44:58Z
dc.date.available2026-10-07T09:44:58Z
dc.date.issued2026-06-15
dc.descriptionResearch Letter
dc.descriptionThe VEBIS Primary Care Vaccine Effectiveness Group Investigators and Coordinators: João Almeida Santos, Licínia Gomes, Ausenda Machado, Raquel Guiomar (INSA).
dc.description.abstractIntroduction: From September to November 2025, many European countries launched COVID-19 vaccination campaigns, when SARS-CoV-2 incidence was decreasing after a period of high circulation.1 These campaigns targeted specific groups, including older adults (ie, individuals aged at or above a minimum threshold that varied from age 60 to 70 years across countries). We estimated the effectiveness of COVID-19 vaccines administered during these seasonal vaccination campaigns in Europe against medically attended, symptomatic SARS-CoV-2 infection among older adults, from September 29, 2025, to January 10, 2026.eng
dc.description.abstractPlain language summary: This case-control study examines COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection among older adults in Europe.eng
dc.description.sponsorshipThis study was funded by the framework contract ECDC/2021/019 from the European Centre for Disease Prevention and Control (ECDC).
dc.identifier.citationJAMA Netw Open. 2026 Jun 1;9(6):e2619040. doi: 10.1001/jamanetworkopen.2026.19040
dc.identifier.doi10.1001/jamanetworkopen.2026.19040
dc.identifier.eissn2574-3805
dc.identifier.pmid42295762
dc.identifier.urihttp://hdl.handle.net/10400.18/11379
dc.language.isoeng
dc.peerreviewedyes
dc.publisherAmerican Medical Association
dc.relation.hasversionhttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2850251
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOVID‐19
dc.subjectSARS‐CoV‐2
dc.subjectVaccine Effectiveness
dc.subjectVEBIS
dc.subjectCuidados de Saúde
dc.subjectInfecções Respiratórias
dc.titleCOVID-19 Vaccine Effectiveness among older adultseng
dc.typejournal article
dcterms.referenceshttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2850251?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&__cf_chl_f_tk=OQuctnnjC6okyGxr3Uzy7vT4kXyg3lLMVvsSTbN4xh0-1783436457-1.0.1.1-2pCUpvAXL0gBZUifcIEfOUymVel234yDZoAEG9HNMwY#supplemental-tab
dspace.entity.typePublication
oaire.citation.issue6
oaire.citation.startPage19040
oaire.citation.titleJAMA Network Open
oaire.citation.volume9
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Delaunay_2026_COVID-19 Vaccine Effectiveness Among Older Adults.pdf
Tamanho:
406.36 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição: